Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -2.56 is 74% above its 5-year average of -9.79, near the high end of its 5-year range (-41.40–1.87).
52.98% above its 12-month average of -5.45.
Reported quarterly EPS; no daily interpolation. Q4 FY2025 (2025-12-31): -1.49.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 5 comparable quarters.
EARNINGS PER SHARE (EPS)
-2.56
EARNINGS PER SHARE (EPS) AVG TTM
-5.45
EARNINGS PER SHARE (EPS) AVG 3Y
-15.27
EARNINGS PER SHARE (EPS) AVG 5Y
-9.79
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+52.98%
CURRENT VS 3Y AVG
+83.24%
CURRENT VS 5Y AVG
+73.85%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
EUDA Health Holdings Limited
Market Cap
$32.31M
Earnings Per Share (EPS)
-2.56
TTM Avg
-5.45
3Y Avg
-15.27
5Y Avg
-9.79
Market Cap
$32.34M
Earnings Per Share (EPS)
-0.48
TTM Avg
-0.42
3Y Avg
-0.82
5Y Avg
-1.14
Market Cap
$32.55M
Earnings Per Share (EPS)
-7.30
TTM Avg
-11.70
3Y Avg
-7.29
5Y Avg
-5.93
Market Cap
$31.52M
Earnings Per Share (EPS)
-1.38
TTM Avg
-0.93
3Y Avg
-0.75
5Y Avg
-0.52
Market Cap
$31.46M
Earnings Per Share (EPS)
-0.17
TTM Avg
-0.24
3Y Avg
-0.47
5Y Avg
-0.92
Market Cap
$33.32M
Earnings Per Share (EPS)
-0.52
TTM Avg
-0.68
3Y Avg
-0.92
5Y Avg
-0.73
Market Cap
$31.23M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.24
3Y Avg
-0.01
5Y Avg
0.39
Market Cap
$30.86M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.73
3Y Avg
-1.47
5Y Avg
-1.95
Market Cap
$34.44M
Earnings Per Share (EPS)
-1.26
TTM Avg
-0.80
3Y Avg
-2.79
5Y Avg
-3.86
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| EUDA Health Holdings Limited (EUDA) | $32.31M | -2.56 | -5.45 | -15.27 | -9.79 |
| Context Therapeutics Inc. (CNTX)vs › | $32.34M | -0.48 | -0.42 | -0.82 | -1.14 |
| Aligos Therapeutics, Inc. (ALGS)vs › | $32.55M | -7.30 | -11.70 | -7.29 | -5.93 |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $31.52M | -1.38 | -0.93 | -0.75 | -0.52 |
| BeyondSpring Inc. (BYSI)vs › | $31.46M | -0.17 | -0.24 | -0.47 | -0.92 |
| HeartBeam, Inc. (BEAT)vs › | $33.32M | -0.52 | -0.68 | -0.92 | -0.73 |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.23M | N/A | -0.24 | -0.01 | 0.39 |
| MDxHealth S.A. (MDXH)vs › | $30.86M | N/A | -0.73 | -1.47 | -1.95 |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.44M | -1.26 | -0.80 | -2.79 | -3.86 |
| CervoMed Inc. (CRVO)vs › | $30.00M | -3.21 | -2.50 | -4.25 | -9.67 |
Trailing EPS (TTM)
$-2.56
Forward EPS (Est.)
$1.60
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.49 |
| 2024-12-31 | -9.40 |
| 2023-12-31 | -8.80 |
| 2022-12-31 | -41.40 |
| 2021-12-31 | 1.87 |
| 2020-12-31 | 0.47 |
